Records 1 - 4 (of 4 Records)
|Query Trace: Gaucher Disease[original query]>>Evidence Synthesis [Product Type]|
| CLINGEN Actionability Report for Gaucher Disease - GBA
ClinGen Actionability Working Group
| Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States.
Nalysnyk Luba et al. Journal of managed care & specialty pharmacy 2018 Oct 24(10) 1002-1008
| Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature.
Voorink-Moret M et al. Molecular genetics and metabolism 2017 Dec
| Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders.
Cassis Linda et al. Orphanet journal of rare diseases 2015 10(1) 164